Australia's Osteopore Ltd gains on collaboration agreement with RxCell
** Shares of Australia's Osteopore Ltd OSX.AX rise as much
as 5.1% to A$0.041, its biggest intraday pct gain since Sept 27
** The medical technology firm signs collaboration agreement
with US-based company RxCell Inc
** Under agreement, both parties will work together to
co-design scaffold-based cellular product — OSX
** Stock has fallen 65.3% YTD, as of 0026 GMT
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
Recent news on Osteopore
See all newsBrief: Osteopore Secures Market Access In Thailand For Full Range Of Orthopaedic Products
Brief: Osteopore Strikes Orthopaedic Deal For 5 Middle East Countries
Brief: Osteopore Achieves Market Access To Saudi Arabia For Craniofacial Products
Brief: Osteopore Launches Clinical Study For Paranasal Augmentation In Patients With Unilateral Cleft Lip
Australia's Osteopore advances on regulatory win in China's Hainan